We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 141 funds opening new positions, 967 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 967 | Existing positions reduced: 887

4% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3882,365 (-23)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-23
Holders Change %
-0.96%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
141
Increased
967
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
AIMCA
876
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$4.5M
BP
877
Ballentine Partners
Massachusetts
$4.5M +$923K +1,733 +24%
BMCM
878
Bryn Mawr Capital Management
Pennsylvania
$4.49M +$433K +812 +10%
LF
879
Longbow Finance
Switzerland
$4.48M -$4.76M -8,938 -50%
UFA
880
US Financial Advisors
Massachusetts
$4.48M -$70.9K -133 -1%
GAB
881
German American Bancorp
Indiana
$4.47M +$135K +253 +3%
HW
882
Hancock Whitney
Mississippi
$4.46M -$229K -430 -5%
OLA
883
Oliver Luxxe Assets
New Jersey
$4.46M +$74.6K +140 +2%
JIC
884
Johnson Investment Counsel
Ohio
$4.45M +$302K +566 +7%
AAIM
885
Asset Advisors Investment Management
Georgia
$4.44M -$414K -777 -8%
O
886
Ossiam
France
$4.44M -$14.9M -27,872 -76%
TCOO
887
Trust Company of Oklahoma
Oklahoma
$4.43M -$70.3K -132 -1%
AWM
888
Apollon Wealth Management
South Carolina
$4.42M -$231K -434 -5%
ZB
889
Zions Bancorporation
Utah
$4.42M +$780K +1,464 +20%
KPWS
890
Kestra Private Wealth Services
Texas
$4.42M +$1.42M +2,658 +44%
TMAM
891
Tokio Marine Asset Management
Japan
$4.39M +$407K +763 +10%
CC
892
Centiva Capital
New York
$4.39M -$5.09M -9,554 -52%
USCWA
893
U.S. Capital Wealth Advisors
Texas
$4.36M +$93.3K +175 +2%
JFG
894
Jefferies Financial Group
New York
$4.34M -$4.56M -8,566 -50%
OCM
895
Orser Capital Management
Texas
$4.31M -$26.6K -50 -0.6%
RP
896
Regal Partners
Australia
$4.29M -$1.18M -2,210 -21%
RCM
897
RNC Capital Management
California
$4.28M +$4.5M +8,454 New
SNBOSD
898
Security National Bank of So Dak
Iowa
$4.27M +$53.3K +100 +1%
BRM
899
Boston Research & Management
Massachusetts
$4.27M +$73.5K +138 +2%
MGWM
900
Marks Group Wealth Management
Minnesota
$4.23M -$53.8K -101 -1%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 135 closed out — a net gain of 6 holders — while 967 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,388 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +6 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.